menu
    • menu
    [{"orgOrder":0,"company":"Mesoestetic Pharma Group","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"SPAIN","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Hydroquinone","moa":"TYR","graph1":"Dermatology","graph2":"Phase III","graph3":"Mesoestetic Pharma Group","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Mesoestetic Pharma Group \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"Mesoestetic Pharma Group \/ Undisclosed"},{"orgOrder":0,"company":"Lutronic","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Miscellaneous","year":"2017","type":"Inapplicable","leadProduct":"Hydroquinone","moa":"TYR","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Lutronic","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Lutronic \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Lutronic \/ Undisclosed"},{"orgOrder":0,"company":"Laboratoire Dermatologique ACM","sponsor":"CIDP Mauritius","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Hydroquinone","moa":"TYR","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Laboratoire Dermatologique ACM","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Laboratoire Dermatologique ACM \/ CIDP Mauritius","highestDevelopmentStatusID":"1","companyTruncated":"Laboratoire Dermatologique ACM \/ CIDP Mauritius"}]

    Find Clinical Drug Pipeline Developments & Deals for Tox21_202345

    Menu

    Tox21_202345

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Laboratoire Dermatologique ACM

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Laboratoire Dermatologique ACM

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Hydroquinone

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : CIDP Mauritius

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            COMPARISON of A COSMETIC SERUM and 4% HYDROQUINONE FOR TREATING MELASMA OVER 84 DAYS

                            Details : Hydroquinone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            July 17, 2025

                            Lead Product(s) : Hydroquinone

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : CIDP Mauritius

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Lutronic

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Lutronic

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Hydroquinone

                            Therapeutic Area : Dermatology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy and Safety of Picosecond, Neodymium-doped Yttrium Aluminum Garnet Laser Therapy Using 1,064 nm and 59...

                            Details : Neoquine (Hydroquinone) is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Melanosis.

                            Product Name : Neoquine

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            February 02, 2017

                            Lead Product(s) : Hydroquinone

                            Therapeutic Area : Dermatology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Mesoestetic Pharma Group

                            Spain arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Mesoestetic Pharma Group

                            Spain arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Hydroquinone

                            Therapeutic Area : Dermatology

                            Study Phase : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma

                            Details : Hydroquinone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Melanosis.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            March 26, 2014

                            Lead Product(s) : Hydroquinone

                            Therapeutic Area : Dermatology

                            Highest Development Status : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth